<SEC-DOCUMENT>0001193125-26-177361-index.html : 20260424
<SEC-HEADER>0001193125-26-177361.hdr.sgml : 20260424
<ACCEPTANCE-DATETIME>20260424162504
ACCESSION NUMBER:		0001193125-26-177361
CONFORMED SUBMISSION TYPE:	ARS
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20251231
FILED AS OF DATE:		20260424
DATE AS OF CHANGE:		20260424
EFFECTIVENESS DATE:		20260424

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apogee Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001974640
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				934958665
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		ARS
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41740
		FILM NUMBER:		26894517

	BUSINESS ADDRESS:	
		STREET 1:		221 CRESCENT ST.
		STREET 2:		BUILDING 17, SUITE 102B
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453
		BUSINESS PHONE:		650-394-5230

	MAIL ADDRESS:	
		STREET 1:		221 CRESCENT ST.
		STREET 2:		BUILDING 17, SUITE 102B
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Apogee Therapeutics, LLC
		DATE OF NAME CHANGE:	20230420
</SEC-HEADER>
<DOCUMENT>
<TYPE>ARS
<SEQUENCE>1
<FILENAME>apge_ars_2026.pdf
<DESCRIPTION>ARS
<TEXT>
Document 1 - file: apge_ars_2026.pdf

</DOCUMENT>
</SEC-DOCUMENT>